Global Trac Solutions, Inc. CEO, David Flores, sits down once again with Founder & CEO of The Third Wave, Paul F. Austin. The two begin their conversation with accessibility & affordability, concepts that are commonly overlooked in psychedelic medicine. They then dive into what it would take to create an infrastructure that ensures a very important segment of our society is able to gain access to the powerful, and profound benefits available through the use of psychedelic medicine.
Similar Posts
Personality Disorders: A Major X-Factor in Psychedelic Therapy
Psychedelics, like humans, vary in nature. A new study highlighting their imperfections is crucial to avoiding the shadows.
Microdosing vs Adderall and Other Traditional ADD Medications
We explore the effectiveness, safety, and potential side effects of microdosing compared to Adderall and other traditional ADD medications.
Mushrooms Have Their Own Language, New Study Suggests
The electric pulses could be organized into “trains” that resemble human words, and a vocabulary of “up to 50 words” appears to be present.
AI Interview on Psychedelics
There is growing interest in AI’s ability to mimic human interactions. We interview OpenAI’s GPT-3 chatbot to see what it knows about psychedelics.
Michael Pollan Explores More Psychedelics In New Book: This Is Your Mind on Plants
New York Times bestselling author Michael Pollan explores mescaline, opium, and caffeine in his forthcoming book “This Is Your Mind on Plants”.
Single Dose of Psilocybin Yields Long-Term Depression Remission in Over 50% of Cancer Patients
A single 25mg dose of psilocybin paired with psychological support has resulted in 57% of patients.